Material used
Details are provided on the label sewn into your wrist
support.
Notes for the orthopaedic technician
The volar stabilising split is thermoplastically deform-
able at 180 °C. When shaping it, use suitable heat
protection gloves to avoid injury.
Storage information and shelf life
Store in a dry place and protect from sunlight. Sup-
ports have a maximum shelf life of 42 months. The
usage period of the medical product is printed on the
box with an hourglass symbol. Body measurements
may change based on the patient's condition and
individual circumstances. We therefore recommend
that medical specialists check body measurements
regularly.
Indications
∙ distortions (sprains / strains)
∙ tendovaginitis (tendosynovitis)
∙ degeneration of the wrist (arthrosis)
∙ inflammation of the wrist (arthritis)
∙ post-traumatic irritation of the wrist
Contraindications
If the following symptoms exist, the support should
only be worn after consultation with the physician:
Arterial insufficiency, lymph drainage disorders,
post-thrombotic syndromes, skin disorders or skin
irritation. Open wounds in the treated body area
should be kept sterile.
The Julius Zorn GmbH Group assumes no liability as
a result of any contraindicated use of this product.
Side effects
There are no known side effects when used as
directed. However, if negative alterations (such as for
example skin irritation) should occur while the use of
our products has been prescribed, please go to your
doctor or your specialist dealer immediately. If an in-
compatibility should be known against one or several
ingredients of this product, please check back with
your doctor before use. If your medical condition de-
teriorates while the use of our products, please go
to your doctor immediately. The manufacturer is not
liable for damages / injuries which have been caused
by improper handling or misuse.
In the case of complaints related to this product, such
as damage to the knitted fabric or problems with the
fit, please contact the specialist dealer directly. Only
serious incidents that may lead to a major deterio-
ration of the patient's medical condition or to death
should be reported to the manufacturer and the rele-
vant authority in the Member State. Serious incidents
are defined in Article 2 (65) Regulation
(EU) 2017/745 (MDR).
Disposal
Your support can be disposed of through normal
waste channels. No special waste disposal require-
ments apply.
EN